CIK 0001861107 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Ceribell, Inc.
Sign in to watch- Ticker
- CBLL
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471785452
- Phone
- (800) 436-0826
- Business address
- 360 N. PASTORIA AVENUE, SUNNYVALE, CA, 94085
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,415,987
- in 16 filings, $3.9M under 10b5-1 plans
Net −$4,415,987. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Chao Xingjuan −$2.5M President and CEO sold 12% of stake
- Blumberg Scott −$938K Chief Financial Officer sold 20% of stake
- Woo Raymond −$417K Chief Technology Officer sold 8% of stake
- Taylor Joseph Michael −$278K Director sold 21% of stake
- Foehr David −$269K Senior VP, Finance and PAO sold 25% of stake
Reading 16 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-08 | ROBERTSON REBECCA B Director | Option exercise 10b5-1 | +5,000 | $2.24 | $11K | 13,388 |
| 2025-12-08 | ROBERTSON REBECCA B Director | Sale 10b5-1 | −5,000 | $20.00 | $100K | 8,388 |
| 2025-12-08 | ROBERTSON REBECCA B Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 10,150 | ||
| 2025-12-04 | Chao Xingjuan President and CEO | Option exercise 10b5-1 | +25,000 | $2.24 | $56K | 823,135 |
| 2025-12-04 | Chao Xingjuan President and CEO | Sale 10b5-1 | −25,000 | $18.82 | $471K | 798,135 |
| 2025-12-04 | Chao Xingjuan President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,000 | 2,551 | ||
| 2025-12-03 | Foehr David Senior VP, Finance and PAO | Sale 10b5-1 | −866 | $16.83 | $15K | 19,384 |
| 2025-12-03 | Foehr David Senior VP, Finance and PAO | Option exercise 10b5-1 | +2,246 | $4.70 | $11K | 21,630 |
| 2025-12-03 | Foehr David Senior VP, Finance and PAO | Sale 10b5-1 | −2,246 | $16.83 | $38K | 19,384 |
| 2025-12-03 | Foehr David Senior VP, Finance and PAO | Option exercise 10b5-1 | +2,153 | $4.70 | $10K | 21,537 |
| 2025-12-03 | Foehr David Senior VP, Finance and PAO | Sale 10b5-1 | −2,153 | $16.83 | $36K | 19,384 |
| 2025-12-03 | Foehr David Senior VP, Finance and PAO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,246 | 70,710 | ||
| 2025-12-03 | Foehr David Senior VP, Finance and PAO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,153 | 68,557 | ||
| 2025-12-02 | ROBERTSON REBECCA B Director | Sale 10b5-1 | −827 | $16.67 | $14K | 8,388 |
| 2025-12-01 | Woo Raymond Chief Technology Officer | Option exercise 10b5-1 | +1,472 | $2.24 | $3K | 169,176 |
| 2025-12-01 | Woo Raymond Chief Technology Officer | Option exercise 10b5-1 | +3,025 | $4.70 | $14K | 172,201 |
| 2025-12-01 | Woo Raymond Chief Technology Officer | Option exercise 10b5-1 | +6,615 | $4.70 | $31K | 178,816 |
| 2025-12-01 | Woo Raymond Chief Technology Officer | Sale 10b5-1 | −11,112 | $12.28 | $136K | 167,704 |
| 2025-12-01 | Woo Raymond Chief Technology Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,472 | 15,746 | ||
| 2025-12-01 | Woo Raymond Chief Technology Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,025 | 47,821 |
Page 13 of 17 · 330 trades